Chemomab Therapeutics Ltd. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Chemomab Therapeutics Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Chemomab Therapeutics Ltd. for March 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 18 2021 | ANCN | Chemomab Therapeut ... | OrbiMed Israel GP Ltd. | 10% Owner | Option Exercise | A | 17.35 | 28,817 | 499,975 | 28,817 | |
Mar 18 2021 | ANCN | Chemomab Therapeut ... | OrbiMed Israel GP Ltd. | 10% Owner | Grant | A | 17.35 | 288,170 | 4,999,750 | 2,578,174 | 2.3 M to 2.6 M (+12.58 %) |
Mar 18 2021 | ANCN | Chemomab Therapeut ... | THIEL PETER | 10% Owner | Option Exercise | P | 17.35 | 23,054 | 400,008 | 23,054 | |
Mar 18 2021 | ANCN | Chemomab Therapeut ... | THIEL PETER | 10% Owner | Buy | P | 0.00 | 230,536 | 0 | 1,108,509 | 878 K to 1.1 M (+26.26 %) |
Mar 12 2021 | ANCN | Anchiano Therapeut ... | Polovets Stanislav | Director | Option Exercise | A | 0.17 | 55,000 | 9,350 | 55,000 | |
Mar 11 2021 | ANCN | Anchiano Therapeut ... | Cohen Neil Harris | interim CEO | Option Exercise | A | 0.17 | 55,000 | 9,350 | 55,000 |